BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10066040)

  • 1. Comparison of 3 quantitative HCV RNA assays--accuracy of baseline viral load to predict treatment outcome in chronic hepatitis C.
    Reichard O; Norkrans G; Frydén A; Braconier JH; Sönnerborg A; Weiland O
    Scand J Infect Dis; 1998; 30(5):441-6. PubMed ID: 10066040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and amplicor monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy.
    Veillon P; Payan C; Picchio G; Maniez-Montreuil M; Guntz P; Lunel F
    J Clin Microbiol; 2003 Jul; 41(7):3212-20. PubMed ID: 12843066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.
    Trabaud MA; Bailly F; Si-Ahmed SN; Chevallier P; Sepetjan M; Colucci G; Trépo C
    J Med Virol; 1997 May; 52(1):105-12. PubMed ID: 9131466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level.
    Kawai S; Yokosuka O; Imazeki F; Saisho H; Mizuno C
    J Med Virol; 2002 Nov; 68(3):343-51. PubMed ID: 12226820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between three quantitative assays in patients with chronic hepatitis C and their relevance in the prediction of response to therapy.
    Pradat P; Chossegros P; Bailly F; Pontisso P; Saracco G; Sauleda S; Thursz M; Tillmann H; Vlassopoulou H; Alberti A; Braconier JH; Esteban JI; Hadziyannis S; Manns M; Rizzetto M; Thomas HC; Trépo C
    J Viral Hepat; 2000 May; 7(3):203-10. PubMed ID: 10849262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA.
    Yu ML; Chuang WL; Chen SC; Lin ZY; Hsieh MY; Wang LY; Chang WY
    J Clin Pathol; 1999 Nov; 52(11):807-11. PubMed ID: 10690168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of viral loads in patients with chronic hepatitis C with AMPLICOR HCV MONITOR version 1.0, COBAS HCV MONITOR version 2.0, and QUANTIPLEX HCV RNA version 2.0 assays.
    Martinot-Peignoux M; Le Breton V; Fritsch S; Le Guludec G; Labouret N; Keller F; Marcellin P
    J Clin Microbiol; 2000 Jul; 38(7):2722-5. PubMed ID: 10878070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring virological responses to interferon-ribavirin and interferon monotherapy of chronic hepatitis C re-treated due to relapse or non-response.
    Westin J; Lindh M; Nenonen N; Lagging LM; Norkrans G; Wejstål R
    Scand J Infect Dis; 2001; 33(2):110-5. PubMed ID: 11233844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of hepatitis C virus core antigen assay in prediction of therapeutic response to interferon and ribavirin combination therapy.
    Takahashi M; Saito H; Higashimoto M; Atsukawa K; Ishii H
    J Clin Microbiol; 2005 Jan; 43(1):186-91. PubMed ID: 15634970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative (COBAS AMPLICOR HCV monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C virus (HCV) RNA detection and quantification: impact on diagnosis and treatment of HCV infections.
    Desombere I; Van Vlierberghe H; Couvent S; Clinckspoor F; Leroux-Roels G
    J Clin Microbiol; 2005 Jun; 43(6):2590-7. PubMed ID: 15956369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of hepatitis C virus RNA predict non-response to interferon therapy: comparison of two commercial assays.
    Soffredini R; Rumi MG; Del Ninno E; Parravicini ML; Russo A; Colombo M
    J Viral Hepat; 1999 Jan; 6(1):65-71. PubMed ID: 10847132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral effect of ribavirin in early non-responders to interferon monotherapy assessed by kinetics of hepatitis C virus RNA and hepatitis C virus core antigen.
    Lunel F; Veillon P; Fouchard-Hubert I; Loustaud-Ratti V; Abergel A; Silvain C; Rifflet H; Blanchi A; Causse X; Bacq Y; Payan C;
    J Hepatol; 2003 Nov; 39(5):826-33. PubMed ID: 14568267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new step toward standardization of serum hepatitis C virus-RNA quantification in patients with chronic hepatitis C.
    Martinot-Peignoux M; Boyer N; Le Breton V; Le Guludec G; Castelnau C; Akremi R; Marcellin P
    Hepatology; 2000 Mar; 31(3):726-9. PubMed ID: 10706564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.
    De Mitri MS; Morsica G; Chen CH; Mele L; Baccarini P; Chianese R; Piccinini A; Lazzarin A; Pisi E
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):255-61. PubMed ID: 9646218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of the automated COBAS AMPLICOR HCV MONITOR test version 2.0 for quantifying serum hepatitis C virus RNA and comparison to the quantiplex HCV version 2.0 test.
    Yu ML; Chuang WL; Dai CY; Chen SC; Lin ZY; Hsieh MY; Wang LY; Chang WY
    J Clin Microbiol; 2000 Aug; 38(8):2933-9. PubMed ID: 10921954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of early virological response to antiviral therapy by comparing four assays for HCV RNA quantitation using the international unit standard: implications for clinical management of patients with chronic hepatitis C virus infection.
    Halfon P; Pénaranda G; Bourlière M; Khiri H; Masseyeff MF; Ouzan D
    J Med Virol; 2006 Feb; 78(2):208-15. PubMed ID: 16372298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of quantification of viral load in patients infected with hepatitis C virus: quantiplex HCV RNA assay and amplicor monitor assay.
    Olaso V; Córdoba J; López B; Argüello L; Molina J; Lainez B; Ortiz V; Pastor M; Prieto M; Berenguer J
    Rev Esp Enferm Dig; 1999 Aug; 91(8):569-82. PubMed ID: 10491489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordance between HCV RNA assays for week 24 HCV RNA determination during pegylated interferon-α/ribavirin treatment for chronic hepatitis C.
    Roomer R; van Vuuren AJ; Schutten M; Heijens A; Janssen HL; de Knegt RJ
    Antivir Ther; 2011; 16(5):771-4. PubMed ID: 21817199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid virological response assessment by Abbott RealTime hepatitis C virus assay for predicting sustained virological responses in patients with hepatitis C virus genotype 1 treated with pegylated-interferon and ribavirin.
    Su PY; Yen HH; Hsu YC; Wu SS; Kor CT; Su WW
    Kaohsiung J Med Sci; 2016 Jul; 32(7):381-6. PubMed ID: 27450028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative measurement of serum HCV RNA in patients with chronic hepatitis C: comparison between Amplicor HCV monitor system and branched DNA signal amplification assay.
    Lu RH; Hwang SJ; Chan CY; Chang FY; Lee SD
    J Clin Lab Anal; 1998; 12(2):121-5. PubMed ID: 9524297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.